Please enable JavaScript to continue using this application.

Compare $AKTS vs $MNKD | Chartloom

Compare

$AKTS vs $MNKD

Aktis Oncology Inc · MannKind Corp

AKTS

Aktis Oncology Inc

MNKD

MannKind Corp

Compare $AKTS vs $MNKD

Comparing Aktis Oncology Inc and MannKind Corp

AKTSAktis Oncology Inc

MNKDMannKind Corp

AKTSAktis Oncology Inc

Market cap

$969M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

99.47x

Rev growth (TTM)

49.9%

YTD performance

-19.0%

52W performance

18688.8%

FCF yield

-12.6%

MNKDMannKind Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.01x

Rev growth (TTM)

30.5%

YTD performance

-41.3%

52W performance

-39.5%

FCF yield

-1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AKTS

MNKD

Detailed metrics comparison

AKTS

Aktis Oncology Inc

MNKD

MannKind Corp

Market Cap

AKTS$969M

MNKD$1.05B

Enterprise Value

AKTS$887M

MNKD$1.57B

Price

AKTS$18.15

MNKD$3.29

P/E Ratio

AKTSN/A

MNKDN/A

P/S Ratio

AKTS73.94x

MNKD2.67x

EV/Sales

AKTS67.65x

MNKD3.98x

EV/EBITDA

AKTS0.00x

MNKD43.92x

P/B Ratio

AKTS2.12x

MNKD69.42x

P/FCF Ratio

AKTSN/A

MNKDN/A

EV/FCF

AKTS-7.29x

MNKD-86.45x

PEG Ratio

AKTSN/A

MNKDN/A

Forward P/E (NTM)

AKTSN/A

MNKDN/A

Forward P/S (NTM)

AKTS99.47x

MNKD2.01x

Revenue (TTM)

AKTS$13M

MNKD$394M

Revenue Growth (YoY)

AKTS49.9%

MNKD30.5%

Forward Rev Growth

AKTS-9.8%

MNKD13.7%

Gross Margin (TTM)

AKTS0.0%

MNKD76.8%

Operating Margin (TTM)

AKTS0.0%

MNKD2.3%

EBITDA Margin (TTM)

AKTS-934.0%

MNKD8.7%

Net Margin (TTM)

AKTS-810.2%

MNKD-10.9%

FCF Margin (TTM)

AKTS-928.1%

MNKD-4.6%

Net Income (TTM)

AKTS$-106M

MNKD$-43M

FCF (TTM)

AKTS$-122M

MNKD$-18M

EPS (TTM)

AKTS-$1.92

MNKD-$0.14

ROE (TTM)

AKTS-3080.0%

MNKD-29771.0%

ROA (TTM)

AKTS-2531.0%

MNKD-619.0%

ROIC (TTM)

AKTS-3080.0%

MNKD-2719.0%

Cash

AKTS$82M

MNKD$53M

Debt

AKTS$0

MNKD$570M

Net Cash/Debt

AKTS$82M

MNKD$-517M

Current Ratio (TTM)

AKTS16.33x

MNKD1.72x

Quick Ratio (TTM)

AKTS16.10x

MNKD1.29x

Debt/Equity (TTM)

AKTS0.00x

MNKD9.95x

Debt/Assets (TTM)

AKTS0.0%

MNKD0.0%

Interest Coverage (TTM)

AKTSN/A

MNKDN/A

Net Debt/EBITDA (TTM)

AKTS0.00x

MNKD0.00x

Beta

AKTS160.56

MNKD1.09

52W Performance

AKTS18688.8%

MNKD-39.5%

YTD Performance

AKTS-19.0%

MNKD-41.3%

% from 52W High

AKTS-46.9%

MNKD-49.5%

% from 52W Low

AKTS907400.0%

MNKD47.5%

Asset Turnover (TTM)

AKTS0.03x

MNKD0.57x

FCF Yield (TTM)

AKTS-12.6%

MNKD-1.7%

Earnings Yield (TTM)

AKTS-11.0%

MNKD-4.1%

Dividend Yield (TTM)

AKTSN/A

MNKDN/A

Rule of 40

AKTS-878.2

MNKD25.8

EV/GP/RG

AKTSN/A

MNKD0.15

Ticker research

View AKTS research View MNKD research

Metric	AKTS Aktis Oncology Inc	MNKD MannKind Corp
Market & Valuation
Market Cap	$969M	$1.05B
Enterprise Value	$887M	$1.57B
Price	$18.15	$3.29
P/E Ratio	N/A	N/A
P/S Ratio	73.94x	2.67x
EV/Sales	67.65x	3.98x
EV/EBITDA	0.00x	43.92x
P/B Ratio	2.12x	69.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.29x	-86.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	99.47x	2.01x
Revenue & Growth
Revenue (TTM)	$13M	$394M
Revenue Growth (YoY)	49.9%	30.5%
Forward Rev Growth	-9.8%	13.7%
Profitability
Gross Margin (TTM)	0.0%	76.8%
Operating Margin (TTM)	0.0%	2.3%
EBITDA Margin (TTM)	-934.0%	8.7%
Net Margin (TTM)	-810.2%	-10.9%
FCF Margin (TTM)	-928.1%	-4.6%
Net Income (TTM)	$-106M	$-43M
FCF (TTM)	$-122M	$-18M
EPS (TTM)	-$1.92	-$0.14
ROE (TTM)	-3080.0%	-29771.0%
ROA (TTM)	-2531.0%	-619.0%
ROIC (TTM)	-3080.0%	-2719.0%
Financial Health
Cash	$82M	$53M
Debt	$0	$570M
Net Cash/Debt	$82M	$-517M
Current Ratio (TTM)	16.33x	1.72x
Quick Ratio (TTM)	16.10x	1.29x
Debt/Equity (TTM)	0.00x	9.95x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	160.56	1.09
52W Performance	18688.8%	-39.5%
YTD Performance	-19.0%	-41.3%
% from 52W High	-46.9%	-49.5%
% from 52W Low	907400.0%	47.5%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.57x
FCF Yield (TTM)	-12.6%	-1.7%
Earnings Yield (TTM)	-11.0%	-4.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-878.2	25.8
EV/GP/RG	N/A	0.15
Ticker research	View AKTS research	View MNKD research

Valuation

P/S Ratio

MNKD

2.67x

AKTS

73.94x

EV/FCF

MNKD

-86.45x

AKTS

-7.29x

Growth & revenue

Revenue Growth TTM

AKTS

49.9%

MNKD

30.5%

Forward Revenue Growth

MNKD

13.7%

AKTS

-9.8%

Profitability & performance

Gross Margin

MNKD

76.8%

AKTS

0.0%

ROE

AKTS

-3080.0%

MNKD

-29771.0%

FCF Yield %

MNKD

-1.7%

AKTS

-12.6%

52-Week Performance

AKTS

18688.8%

MNKD

-39.5%

Detailed metrics comparison

AKTS

Aktis Oncology Inc

MNKD

MannKind Corp

Market Cap

AKTS$969M

MNKD$1.05B

Enterprise Value

AKTS$887M

MNKD$1.57B

Price

AKTS$18.15

MNKD$3.29

P/E Ratio

AKTSN/A

MNKDN/A

P/S Ratio

AKTS73.94x

MNKD2.67x

EV/Sales

AKTS67.65x

MNKD3.98x

EV/EBITDA

AKTS0.00x

MNKD43.92x

P/B Ratio

AKTS2.12x

MNKD69.42x

P/FCF Ratio

AKTSN/A

MNKDN/A

EV/FCF

AKTS-7.29x

MNKD-86.45x

PEG Ratio

AKTSN/A

MNKDN/A

Forward P/E (NTM)

AKTSN/A

MNKDN/A

Forward P/S (NTM)

AKTS99.47x

MNKD2.01x

Revenue (TTM)

AKTS$13M

MNKD$394M

Revenue Growth (YoY)

AKTS49.9%

MNKD30.5%

Forward Rev Growth

AKTS-9.8%

MNKD13.7%

Gross Margin (TTM)

AKTS0.0%

MNKD76.8%

Operating Margin (TTM)

AKTS0.0%

MNKD2.3%

EBITDA Margin (TTM)

AKTS-934.0%

MNKD8.7%

Net Margin (TTM)

AKTS-810.2%

MNKD-10.9%

FCF Margin (TTM)

AKTS-928.1%

MNKD-4.6%

Net Income (TTM)

AKTS$-106M

MNKD$-43M

FCF (TTM)

AKTS$-122M

MNKD$-18M

EPS (TTM)

AKTS-$1.92

MNKD-$0.14

ROE (TTM)

AKTS-3080.0%

MNKD-29771.0%

ROA (TTM)

AKTS-2531.0%

MNKD-619.0%

ROIC (TTM)

AKTS-3080.0%

MNKD-2719.0%

Cash

AKTS$82M

MNKD$53M

Debt

AKTS$0

MNKD$570M

Net Cash/Debt

AKTS$82M

MNKD$-517M

Current Ratio (TTM)

AKTS16.33x

MNKD1.72x

Quick Ratio (TTM)

AKTS16.10x

MNKD1.29x

Debt/Equity (TTM)

AKTS0.00x

MNKD9.95x

Debt/Assets (TTM)

AKTS0.0%

MNKD0.0%

Interest Coverage (TTM)

AKTSN/A

MNKDN/A

Net Debt/EBITDA (TTM)

AKTS0.00x

MNKD0.00x

Beta

AKTS160.56

MNKD1.09

52W Performance

AKTS18688.8%

MNKD-39.5%

YTD Performance

AKTS-19.0%

MNKD-41.3%

% from 52W High

AKTS-46.9%

MNKD-49.5%

% from 52W Low

AKTS907400.0%

MNKD47.5%

Asset Turnover (TTM)

AKTS0.03x

MNKD0.57x

FCF Yield (TTM)

AKTS-12.6%

MNKD-1.7%

Earnings Yield (TTM)

AKTS-11.0%

MNKD-4.1%

Dividend Yield (TTM)

AKTSN/A

MNKDN/A

Rule of 40

AKTS-878.2

MNKD25.8

EV/GP/RG

AKTSN/A

MNKD0.15

Ticker research

View AKTS research View MNKD research

Metric	AKTS Aktis Oncology Inc	MNKD MannKind Corp
Market & Valuation
Market Cap	$969M	$1.05B
Enterprise Value	$887M	$1.57B
Price	$18.15	$3.29
P/E Ratio	N/A	N/A
P/S Ratio	73.94x	2.67x
EV/Sales	67.65x	3.98x
EV/EBITDA	0.00x	43.92x
P/B Ratio	2.12x	69.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.29x	-86.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	99.47x	2.01x
Revenue & Growth
Revenue (TTM)	$13M	$394M
Revenue Growth (YoY)	49.9%	30.5%
Forward Rev Growth	-9.8%	13.7%
Profitability
Gross Margin (TTM)	0.0%	76.8%
Operating Margin (TTM)	0.0%	2.3%
EBITDA Margin (TTM)	-934.0%	8.7%
Net Margin (TTM)	-810.2%	-10.9%
FCF Margin (TTM)	-928.1%	-4.6%
Net Income (TTM)	$-106M	$-43M
FCF (TTM)	$-122M	$-18M
EPS (TTM)	-$1.92	-$0.14
ROE (TTM)	-3080.0%	-29771.0%
ROA (TTM)	-2531.0%	-619.0%
ROIC (TTM)	-3080.0%	-2719.0%
Financial Health
Cash	$82M	$53M
Debt	$0	$570M
Net Cash/Debt	$82M	$-517M
Current Ratio (TTM)	16.33x	1.72x
Quick Ratio (TTM)	16.10x	1.29x
Debt/Equity (TTM)	0.00x	9.95x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	160.56	1.09
52W Performance	18688.8%	-39.5%
YTD Performance	-19.0%	-41.3%
% from 52W High	-46.9%	-49.5%
% from 52W Low	907400.0%	47.5%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.57x
FCF Yield (TTM)	-12.6%	-1.7%
Earnings Yield (TTM)	-11.0%	-4.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-878.2	25.8
EV/GP/RG	N/A	0.15
Ticker research	View AKTS research	View MNKD research